FDA Inspection 903523 — Halo Pharmaceutical Canada Inc
The FDA completed an inspection of Halo Pharmaceutical Canada Inc on Nov 14, 2014 in Mirabel. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 14, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mirabel (Canada)